---
title: "GEMPHARMATECH's net profit for the year 2024 is 116 million yuan, a year-on-year decrease of 27.14%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229894716.md"
description: "According to the Zhitong Finance APP, GEMPHARMATECH released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 687 million yuan, an increase of 10.38% compared to the same period last year; the net profit attributable to the owners of the parent company was 116 million yuan, a decrease of 27.14% compared to the same period last year"
datetime: "2025-02-27T10:23:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229894716.md)
  - [en](https://longbridge.com/en/news/229894716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229894716.md)
generator: "portal-rs"
---

# GEMPHARMATECH's net profit for the year 2024 is 116 million yuan, a year-on-year decrease of 27.14%

According to the Zhitong Finance APP, GEMPHARMATECH (688046.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 687 million yuan, an increase of 10.38% compared to the same period last year; the net profit attributable to the owners of the parent company was 116 million yuan, a decrease of 27.14% compared to the same period last year

### Related Stocks

- [688046.CN](https://longbridge.com/en/quote/688046.CN.md)

## Related News & Research

- [In Focus|Faster and cheaper: why Hongkongers are heading north for medical care](https://longbridge.com/en/news/297988414.md)
- [Baidu’s Xiaodu schedules AI hardware launch for Sept. 8](https://longbridge.com/en/news/298171383.md)
- [Mabwell reports Phase Ib/IIa data showing anti-ST2 antibody 9MW1911 cuts COPD exacerbations up to 81%](https://longbridge.com/en/news/298042457.md)
- [Xiaomi’s SU7 Ultra test car points to a more performance-focused model](https://longbridge.com/en/news/297995487.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**